CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND DRUG CHEMISTRY SUPPORT

癌症预防部（DCP），NCI，保持药物开发计划，以支持有前途的实验室发现转化为有效的医疗干预措施，以预防或减少癌症。 实施该计划所需的服务多种多样且高度专业化。这需要一个多功能的操作，能够提供体外和体内临床前疗效评估，癌症预防司快速获得预防干预开发（RAPID）计划，临床前毒理学研究和人体临床试验的开发服务。 该储存库维护了一个集中的药物来源和支持化学预防研究所需的开发服务。储存库为化学预防研究的研究药物的获取、跟踪、储存、维护、测试、质量控制和分配提供了重要的后勤组织。

The Division of Cancer Prevention (DCP), NCI, maintains a pharmaceutical development program to support the translation of promising laboratory discoveries for the prevention or reduction of cancer into effective medical interventions. The services required to implement this program are diverse and highly specialized. This requires a versatile operation capable of supplying agents for in-vitro and in-vivo pre-clinical efficacy evaluations, development services for the Division of Cancer Prevention¿s Rapid Access to Preventive Intervention Development (RAPID) program, pre-clinical toxicology studies and human clinical trials. The Repository maintains a centralized source of agents and development services necessary to support chemoprevention studies. The repository provides important logistic organization for the acquisition, tracking, storage, maintenance, testing, quality control, and distribution of investigational agents for the study of chemoprevention.